Hofseth BioCare ASA (OSL:HBC)
Norway · Delayed Price · Currency is NOK 1.345
+0.030 (2.28%)
Aug 4, 2026, 4:25 PM CET
Hofseth BioCare ASA Cash Flow Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -138.16 | -134.71 | -125.3 | -106.68 | -137.39 | -126.46 |
Depreciation & Amortization | 40.3 | 39.41 | 39.78 | 36.41 | 30.41 | 29.35 |
Stock-Based Compensation | 52.5 | 52.5 | 144 | 0 | - | - |
Other Adjustments | -3.64 | -0.4 | -0.64 | -20.95 | -0.2 | 7.56 |
Change in Receivables | 2.17 | -2.67 | -4 | -0.78 | -3.98 | 4.18 |
Changes in Inventories | -5.68 | -3.91 | 26.63 | 33.98 | -25.71 | -17.51 |
Changes in Accounts Payable | 6.04 | 0.99 | 38.47 | -90.59 | 70.36 | 39.21 |
Changes in Accrued Expenses | - | 2.88 | -144.4 | - | - | - |
Changes in Income Taxes Payable | - | 0.18 | 0 | 0 | 0 | 0 |
Changes in Other Operating Activities | 5.36 | - | - | 141.87 | 11.4 | 0.1 |
Operating Cash Flow | -15.19 | -27.81 | -11.4 | 2.76 | -45.17 | -61.78 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -34.95 | -19.73 | -2.44 | -8.19 | -4.02 | -22.92 |
Sale of Property, Plant & Equipment | - | 0 | 0 | 0.69 | - | - |
Purchases of Intangible Assets | -0.4 | -0.73 | -1.63 | -5.87 | -13.76 | -14.83 |
Purchases of Investments | - | 0 | 0 | -1.62 | 0 | -0.19 |
Investing Cash Flow | -35.35 | -20.47 | -4.07 | -14.99 | -17.78 | -37.94 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 8.78 | 19.4 | 28.35 | - | - |
Net Short-Term Debt Issued (Repaid) | - | 8.78 | 19.4 | 28.35 | - | - |
Long-Term Debt Issued | 76.84 | 115.82 | 25.1 | 0 | 0 | 1.09 |
Long-Term Debt Repaid | -25.16 | -14.04 | -12.98 | -13.41 | -15.05 | -14.89 |
Net Long-Term Debt Issued (Repaid) | 51.67 | 101.78 | 12.12 | -13.41 | -15.05 | -13.8 |
Issuance of Common Stock | - | - | - | - | 70.78 | 0 |
Net Common Stock Issued (Repurchased) | - | - | - | - | 70.78 | 0 |
Other Financing Activities | -5.84 | -1.15 | -0.29 | -0.22 | -0.33 | -7.6 |
Financing Cash Flow | 21.59 | 91.5 | 17.16 | 3.69 | 45.45 | -23.2 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | -1.76 | 0 | - | - | - |
Net Cash Flow | -28.95 | 43.23 | 1.69 | -8.54 | -17.49 | -122.91 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -50.14 | -47.54 | -13.84 | -5.43 | -49.19 | -84.7 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -20.47% | -18.54% | -5.21% | -2.49% | -40.84% | -96.68% |
Free Cash Flow Per Share | -0.12 | -0.11 | -0.03 | -0.01 | -0.13 | -0.24 |
Levered Free Cash Flow | -75.59 | -4.5 | -135.75 | 21.74 | -70 | -112.05 |
Unlevered Free Cash Flow | -105.54 | -92.68 | -147.05 | 10.95 | -46.18 | -90.35 |